Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Oct;60(4):634–637. doi: 10.1038/bjc.1989.329

The clinical correlates of serum CA125 in 169 patients with epithelial ovarian carcinoma.

R E Hawkins 1, K Roberts 1, E Wiltshaw 1, J Mundy 1, V R McCready 1
PMCID: PMC2247108  PMID: 2803938

Abstract

Serial CA125 measurements in 169 patients with epithelial ovarian carcinoma were obtained. Changes in serum CA125 measurements are shown to reflect changes in clinical status. For patients with macroscopic disease receiving chemotherapy, the sensitivity and specificity for predicting response are shown to be 95% and 86% respectively. For patients with no known disease, the sensitivity and specificity for detecting relapse are shown to be 86% and 91% respectively. The clinical correlates with the level of serum CA125 were examined and the most important is shown to be amount of residual disease.

Full text

PDF
637

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bast R. C., Jr, Feeney M., Lazarus H., Nadler L. M., Colvin R. B., Knapp R. C. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981 Nov;68(5):1331–1337. doi: 10.1172/JCI110380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bast R. C., Jr, Klug T. L., St John E., Jenison E., Niloff J. M., Lazarus H., Berkowitz R. S., Leavitt T., Griffiths C. T., Parker L. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983 Oct 13;309(15):883–887. doi: 10.1056/NEJM198310133091503. [DOI] [PubMed] [Google Scholar]
  3. Bergmann J. F., Bidart J. M., George M., Beaugrand M., Levy V. G., Bohuon C. Elevation of CA 125 in patients with benign and malignant ascites. Cancer. 1987 Jan 15;59(2):213–217. doi: 10.1002/1097-0142(19870115)59:2<213::aid-cncr2820590206>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  4. Canney P. A., Moore M., Wilkinson P. M., James R. D. Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker. Br J Cancer. 1984 Dec;50(6):765–769. doi: 10.1038/bjc.1984.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fleuren G. J., Nap M., Aalders J. G., Trimbos J. B., de Bruijn H. W. Explanation of the limited correlation between tumor CA 125 content and serum CA 125 antigen levels in patients with ovarian tumors. Cancer. 1987 Nov 15;60(10):2437–2442. doi: 10.1002/1097-0142(19871115)60:10<2437::aid-cncr2820601015>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  6. Haga Y., Sakamoto K., Egami H., Yoshimura R., Akagi M. Evaluation of serum CA125 values in healthy individuals and pregnant women. Am J Med Sci. 1986 Jul;292(1):25–29. doi: 10.1097/00000441-198607000-00005. [DOI] [PubMed] [Google Scholar]
  7. Haga Y., Sakamoto K., Egami H., Yoshimura R., Mori K., Akagi M. Clinical significance of serum CA125 values in patients with cancers of the digestive system. Am J Med Sci. 1986 Jul;292(1):30–34. doi: 10.1097/00000441-198607000-00006. [DOI] [PubMed] [Google Scholar]
  8. Halila H., Stenman U. H., Seppälä M. Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy. Cancer. 1986 Apr 1;57(7):1327–1329. doi: 10.1002/1097-0142(19860401)57:7<1327::aid-cncr2820570713>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  9. Heinonen P. K., Tontti K., Koivula T., Pystynen P. Tumour-associated antigen CA 125 in patients with ovarian cancer. Br J Obstet Gynaecol. 1985 May;92(5):528–531. doi: 10.1111/j.1471-0528.1985.tb01360.x. [DOI] [PubMed] [Google Scholar]
  10. Kabawat S. E., Bast R. C., Welch W. R., Knapp R. C., Colvin R. B. Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types. Am J Clin Pathol. 1983 Jan;79(1):98–104. doi: 10.1093/ajcp/79.1.98. [DOI] [PubMed] [Google Scholar]
  11. Klug T. L., Bast R. C., Jr, Niloff J. M., Knapp R. C., Zurawski V. R., Jr Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas. Cancer Res. 1984 Mar;44(3):1048–1053. [PubMed] [Google Scholar]
  12. Redman C. W., Jones S. R., Luesley D. M., Nicholl S. E., Kelly K., Buxton E. J., Chan K. K., Blackledge G. R. Peritoneal trauma releases CA125? Br J Cancer. 1988 Oct;58(4):502–504. doi: 10.1038/bjc.1988.250. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES